Serum Institute to double investment in Biocon Biologics to $300 million

Serum Institute of Life Sciences (SILS) has converted a $150 million loan into equity, increasing its stake in Biocon Biologics. This latest investment adds to the $150 million SILS invested in the firm in November 2022, taking its total equity investment in BBL to $300m.

from Industry-Economic Times https://ift.tt/vKrcT7U
via IFTTT